MedTrace Logo

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

NCT00898963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2020-07-31

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients respond to treatment.

PURPOSE: This laboratory study is looking at biomarkers in patients with stage III or stage IV follicular lymphoma treated on clinical trial E-1496.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

polymorphism analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

OTHER

immunologic technique

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Randall D. Gascoyne, MD · British Columbia Cancer Agency

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-18
Primary Completion
2011-02-11
Completion
2011-02-11

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898963 on ClinicalTrials.gov